Screening compound: PDYMRDSGTMGWTR-WAHFGQRYSA-N

Screening compound: PDYMRDSGTMGWTR-WAHFGQRYSA-N
Screening compound: PDYMRDSGTMGWTR-WAHFGQRYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
PDYMRDSGTMGWTR-WAHFGQRYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C073-4235

Molecular Formula

C32H37ClN4O4 (C32 H37 ClN4 O4)

Compound Name

(1S,2R,5S,7R)-3-{2-[benzyl(methyl)amino]ethyl}-N~6~-(3-chlorophenyl)-N~2~-cyclohexyl-4-oxo-10-oxa-3-azatricyclo[5.2.1.0~1,5~]dec-8-ene-2,6-dicarboxamide

IUPAC name

(5S7R)-3-{2-[benzyl(methyl)amino]ethyl}-N6-(3-chlorophenyl)-N2-cyclohexyl-4-oxo-10-oxa-3-azatricyclo[5.2.1.0^{15}]dec-8-ene-26-dicarboxamide

SMILES

CN(CCN(C([C@]1([C@H]2C3C(Nc4cccc(Cl)c4)=O)O[C@H]3C=C1)C(NC1CCCCC1)=O)C2=O)Cc1ccccc1

InChI

InChI=1S/C32H37ClN4O4/c1-36(20-21-9-4-2-5-10-21)17-18-37-28(30(39)34-23-12-6-3-7-13-23)32-16-15-25(41-32)26(27(32)31(37)40)29(38)35-24-14-8-11-22(33)19-24/h2,4-5,8-11,14-16,19,23,25-28H,3,6-7,12-13,17-18,20H2,1H3,(H,34,39)(H,35,38)/t25-,26?,27-,28?,32-/m0/s1

InChI Key

PDYMRDSGTMGWTR-WAHFGQRYSA-N

MDL Number (MFCD)

PDYMRDSGTMGWTR-WAHFGQRYSA-N in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

Antiviral Library (67538 compounds)

CORONAVIRUS Library (20774 compounds)

Cyclic Ugi PPI Library (9586 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with PDYMRDSGTMGWTR-WAHFGQRYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound PDYMRDSGTMGWTR-WAHFGQRYSA-N?
Check Price and Availability of PDYMRDSGTMGWTR-WAHFGQRYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of PDYMRDSGTMGWTR-WAHFGQRYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for PDYMRDSGTMGWTR-WAHFGQRYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for PDYMRDSGTMGWTR-WAHFGQRYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of PDYMRDSGTMGWTR-WAHFGQRYSA-N available by request